AVALIAÇÃO DAS COMPLICAÇÕES EM PACIENTES COM DIABETES MELLITUS TIPO 1 ATENDIDOS EM UMA CLÍNICA PARTICULAR ESPECIALIZADA E AMBULATÓRIO PÚBLICO DE JOINVILLE - SC
Keywords:
Diabetes Mellitus Tipo 1. Complicações crônicas. Controle glicêmico. Rede Pública. Rede Privada.Abstract
Este trabalho teve como objetivo avaliar o controle metabólico e a prevalência de complicações em pacientes com diagnóstico de diabetes mellitustipo 1 (DM1) atendidos em uma clínica privada e em um ambulatório público em Joinville – SC. Realizou-se um estudo descritivo e retrospectivo, onde foram analisados 64 prontuários de pacientes com diagnóstico de DM1, sendo 25 da rede pública (RP) e 39 da privada (RPV). Observamos que na RP a idade média ao diagnóstico do DM1 foi 16,2 (±7,63) contra 12,8 (±9,80) anos na RPV, que foram realizadas em média 1,9 (±1,2) consultas nos últimos 12 meses na RP e 3,0 (±1,3) na RPV. Em relação à presença de complicações microvasculares, havia informação da presença de retinopatia em 8 de 48 pacientes (16,7%), de nefropatia em 12 de 54 pacientes (22,2%) e neuropatia em 8 de 50 pacientes (16%). Quanto ao controle metabólico, apenas 2 pacientes (8%) de RP e 10 (25%) da RPV apresentavam HbA1c < 7,0%. A maioria dos pacientes, tanto da RP quanto da RPV, atingiu a meta de colesterol total (78,3 e 86,8%), que define bom controle clínico e metabólico do diabetes tipo 1, segundo a Associação Americana de Diabetes (ADA). Os dados mostrama dificuldade de se atingir um bom controle glicêmico, independente do local de atendimento (público ou privado), embora o grupo RPV tenha apresentado um maior percentual de pacientes que atingiram as metas de bom controle clínico e metabólico do diabetes tipo 1 definidas pela ADA, inclusive menor índice de tabagismo e etilismo.
References
De fronzo R, Ferrannini E, Zimmet P. International textbook of diabetes mellitus. 4th ed. Wiley-blackwell. 2015.
Zulian LR, Santos MA, Veras VS, et al. Qualidade de vida de pacientes com diabetes utilizando o instrumento Diabetes 39 (D-39). Rev. Gaúcha Enferm. 2013;34(3):138-146.
Oliveira JEP, Montenegro Junior RM, Vencio S. Diretrizes da Sociedade Brasileira de Diabetes 2017-2018, Ed Clannad, 2017.
International Diabetes Federation. IDF Diabetes Atlas, 8th ed. Brussels, Belgium: International Diabetes Federation, 2017.
Russell ND, Cooper ME. 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications. Diabetologia. 2015; 58:1708-14.
de Boer IH, Rue TC, Cleary PA et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: An analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med. 2011; 171 (5):412-20.
Yau JW, Rogers SL, Kawasaki R, et al. Global Prevalence and Major Risk Factors of Diabetic Retinopathy. Diabetes Care. 2012;35(3):556-564, 2012.
Zargar AH, Wani AI, Masoodi SR, et al. Causes of mortality in diabetes mellitus: data from a tertiary teaching hospital in India. Postgraduate Medical Journal. 2009;85(1003):227-232.
Tapp R, Shaw J. Epidemiology of diabetic neuropathy. In: Tesfaye S, Boulton AJM, editors. Diabetic Neuropathy. Oxford: Oxford Diabetes Library; 2009. p. 1-8.
Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. The Lancet. 2012;380(9854):1662-1673.
Triolo TM, Armstrong TK, McFann K, et al. Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset. Diabetes Care. 2011;34(5):1211–1213.
Suh S, Kim K. Diabetes and Cancer: Is Diabetes Causally Related to Cancer? Diabetes & Metabolism Journal. 2011;35(3);193.
Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999;22(1):99-111
Cheung BM, Ong KL et al. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009 May; 122(5):443-53.
Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-9.
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-12
Chaturvedi N, Fuller JH, Taskinen MR. Differing Associations of Lipid and Lipoprotein Disturbances with the Macrovascular and Microvascular Complications of Type 1 Diabetes. Diabetes Care. 2001;24:2071-7.
Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care. 2006;29:1220-6
Standards of Medical Care in Diabetes. American Diabetes Association. Diabetes Care. 2019;42(1): S61-S70. https://doi.org/10.2337/dc19-S006
Arcanjo CL, Piccirillo LJ, Machado IV, Andrade Jr CRM, Clemente EL, Gomes MB. Avaliação de dislipidemia e de índices antropometricos em pacientes com diabetes mellitus tipo 1. Arq Bras Endocrinol Metab. 2005;49:951-8.
Gomes MB, Tannus LR, Matheus AS, et al. Prevalence, awareness, and treatment of hypertension in patients with type 1 diabetes: a nationwide multicenter study in Brazil. International Journal of Hypertension. 2013;2013:1-8.
Gomes MB, Coral M, Cobas RA, et al. Prevalence of adults with type1 diabetes who meet the goals of care in daily clinical practice: a nationwide multicenter study in Brazil. Diabetes Research and Clinical Practice. 2012;97(1):63–70.
Cobas RA, Ferraz MB, Matheus AS, et al. The cost of type 1 diabetes: a nationwide multicenter study in Brazil. WHO. 2013;91(6):434-440.
Secrest AM, Costacou T, Gutelius B et al. Associations Between Socioeconomic Status and Major Complications in Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. Ann Epidemiol. 2011;21(5):374-381.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Arquivos Catarinenses de Medicina
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
